<html>
<head>PUBMED IDs for KILLER</head>
<body bgcolor='#C5F0F2'><h1>KILLER</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9326928/'>KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene.</a> November 5  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9563466/'>p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha.</a> May 1  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9721851/'>Rare loss-of-function mutation of a death receptor gene in head and neck cancer.</a> August 29  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10101800/'>Regulation of p53 downstream genes.</a> April 2  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10321740/'>Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity.</a> May 13  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10383128/'>Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor.</a> June 26  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10597242/'>Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest.</a> December 22  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10762627/'>Homozygous deletion of the death receptor DR4 gene in a nasopharyngeal cancer cell line is associated with TRAIL resistance.</a> April 14  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10777207/'>Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.</a> April 25  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10810622/'>KILLER/DR5, a novel DNA-damage inducible death receptor gene, links the p53-tumor suppressor to caspase activation and apoptotic death.</a> May 16  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10810619/'>The use of skeletal muscle to express genes for the treatment of cancer.</a> May 16  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10810618/'>Cochleates. Lipid-based vehicles for gene delivery-concept, achievements and future development.</a> May 16  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10810617/'>Polyoma and papilloma virus vectors for cancer gene therapy.</a> May 16  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10933923/'>The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis.</a> August 10  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10930093/'>Coordinated regulation of two TRAIL-R2/KILLER/DR5 mRNA isoforms by DNA damaging agents, serum and 17beta-estradiol in human breast cancer cells.</a> August 10  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11059770/'>Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells.</a> November 4  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11172588/'>Enhanced TRAIL sensitivity by p53 overexpression in human cancer but not normal cell lines.</a> February 15  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11410508/'>Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer.</a> June 19  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11498783/'>Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo.</a> August 11  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11526513/'>Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells.</a> August 30  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11677215/'>Inactivating mutations of KILLER/DR5 gene in gastric cancers.</a> October 26  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12174820/'>The mutant p53-conformation modifying drug, CP-31398, can induce apoptosis of human cancer cells and can stabilize wild-type p53 protein.</a> August 15  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/14999771/'>Mutation analysis of the apoptotic &quot;death-receptors&quot; and the adaptors TRADD and FADD/MORT-1 in osteosarcoma tumor samples and osteosarcoma cell lines.</a> March 5  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15128592/'>TRAIL and KILLER are expressed and induce apoptosis in the murine preimplantation embryo.</a> May 7  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15374982/'>Inducible silencing of KILLER/DR5 in vivo promotes bioluminescent colon tumor xenograft growth and confers resistance to chemotherapeutic agent 5-fluorouracil.</a> September 18  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15632181/'>Linking of N-Myc to death receptor machinery in neuroblastoma cells.</a> January 6  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15766588/'>Infrequent mutation of TRAIL receptor 2 (TRAIL-R2/DR5) in transitional cell carcinoma of the bladder with 8p21 loss of heterozygosity.</a> March 16  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16835297/'>Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts.</a> July 13  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17627287/'>HIPK2-induced p53Ser46 phosphorylation activates the KILLER/DR5-mediated caspase-8 extrinsic apoptotic pathway.</a> July 14  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/23813857/'>The TRAIL of oncogenes to apoptosis.</a> March 19  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23813847/'>The association of genetic variants of matrix metalloproteinases with abdominal aortic aneurysm: a systematic review and meta-analysis.</a> March 19  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23813842/'>NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice.</a> April 29  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/27042744/'>KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR GENES AND THEIR HLA-C LIGANDS IN HASHIMOTO THYROIDITIS IN A CHINESE POPULATION.</a> May 24  2016<br></body></html>
